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Target 
screening
• Known EPs
• Analytical 
standards 
available
Suspect 
screening
• List of possible 
EPs and their 
TPs (literature 
& prediction 
models)
Non-target 
screening
• Unknown 
compounds
• post-acquisition 
data tools 
Identification Approaches
Workflows
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IDENTIFICATION LEVELS
Schymanski et al. Environmental Science and Technology (2014) 48(4):2097
Location: WWTP of Athens, Greece
Period: March 2014
Samples:
• 24-h composite flow-proportional samples of
influent wastewaters & effluent wastewaters
over a week (7 consecutive days)
• 2-h composite flow-proportional samples of influent wastewaters
(Thursday & Saturday, 12 samples per day, from 02:00 to 00:00)
Sampling
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Sample Preparation - Analysis
• 200 mL filtered wastewater (pH adjusted to 6.5)
• Isotopically labelled internal standards were added (100 ng/L)
• Mixed SPE with 4 sorbents:
(Strata X copolymer, Strata-X-AW, Strata-X-CW, IsoluteENV+)
• Extraction: Neutral, Basic & Acidic Compounds
• Evaporation/reconstitution to a final volume of 200 μL
HPLC-HRMS
-QTOF-MS/MS
Non-target screening: 
AutoMS/MS
Target & Suspect 
Analysis:
bbCID
I. Target Screening
• more than 700 pesticides
• more than 800 EPs & TPs
…including information over:
1500 compounds 
for positive ESI 
screening
500 compounds 
for negative ESI 
target screening
~200 common compounds
in-house database:
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I. Target Screening
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Criteria
• deltaRT ≤ 0.05 min
• Accuracy: Error ≤ 5 ppm
• Isotopic fit: ≤ 20 mSigma
• MS/MS fragments, ion ratio
• Ion Intensity > 500 (+ESI) / 200 (-ESI)
• Area > 2000 (+ESI) / 800 (-ESI)
83 % of analytes 
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I. Target ScreeningValidation 
ü Linearity in stds, spiked samples & 
matrix-matched samples
R2> 0.92- 0.9999
ü Repeatability:   %RSD <20%
ü% Recoveries
ü LODs
200 target compounds
− 170 positive ESI
− 50 negative ESI
Over the whole range of 
database
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I. Target Screening
4.0 ng/L (Primidone) –
26.1 μg/L (Caffeine)
0.5 mg/L (Metformin)
Results
effluent influent
123 Compounds detected 176
75 pharmaceuticals & drugs of abuse 103
23 pesticides 39
6 PFCs 6
4 sweeteners 4
10 Disinfection by-products & PCP 19
5 Aminoacids 5
Sat. 15/03/14
24-h composite wastewater
Sat. 15/03/14
2-h influent wastewater
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I. Target Screening
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II. Suspect Screening
• more than 10000 EPs and TPs
…including information over:
from literature 
from prediction models 
(UM-PPS, Metabolite Predict) 
from regulation bodies
(REACH)
1. in-house database
2. Retention time prediction tool
KNN-GA-SVM
3. High Resolution Mass Spectral Libraries
for MS/MS data (MassBank, MetFrag)
Retention Time Prediction Models
QSAR/QSPR procedure:
1. Optimization by HyperChem / MOPAC
2. Molecular descriptors by Dragon (zero, constant and near-
constant, and collinear descriptors were removed)
3. Division of dataset to training and test datasets by clustering 
(KNN) or PCA
4. Selection of the relevant descriptors by Stepwise or Genetic 
algorithm 
5. Build of models by MLR, ANNs, and SVM and their 
comparison
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Data set was gathered and drawn then 
optimized using Hyperchem package. 
Cluster Analysis 
 
PCA 
 
Genetic 
algorithm 
 
Stepwise Genetic 
algorithm 
 
Stepwise 
KNN-GA-MLR 
KNN-GASVM 
KNN-GA-ANN 
 
KNN-SW-MLR 
KNN-SW-SVM 
KNN-SW-ANN 
 
KNN-GA-MLR compare with PCA-GA-MLR          KNN-SW-MLR compare with PCA-SW-MLR 
KNN-GASVM compare with PCA-GA-SVM           KNN-SW-SVM compare with PCA-SW-SVM 
KNN-GA-ANN compare with PCA-GA-ANN          KNN-SW-ANN compare with PCA-SW-ANN 
 
KNN-GA-MLR compare with KNN-SW-MLR 
KNN-GA-SVM compare with KNN-SW-SVM 
KNN-GA-ANN compare with KNN-SW-ANN 
PCA-GA-MLR 
PCA -GASVM 
PCA -GA-ANN 
 
PCA -SW-MLR 
PCA –SW-SVM 
PCA -SW-ANN 
 
Interpretation of Descriptors 
 
Retention Time Predictor software (RTP) 
 
R² = 0.9508
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KNN-GA-SVM – (-) ESI compounds 
KNN-GA-SVM plot – (+) ESI Compounds
The best prediction accuracy was achieved by KNN-GA-SVM model for 
both positive and negative ESI compounds.
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II. Suspect ScreeningOptimization & 
Validation 
ü Peak Area/Intensity Ratio > 4
ü False Negative Results <10%
Criteria
…in order exclude too many 
irrelevant peaks !
Peak Area: 20,000
Intensity: 5,000
Thresholds
+ ESI
Peak Area: 2,000
Intensity: 500
- ESI
Application to “artificial” suspect
at 5 concentration levels (1 – 0.025 μg/L) 
C (μg/L) +ESI -ESI
1 9.8 0
0.5 11 6.2
0.25 19 27
0.05 61 40
0.025 88 50
% False Negative
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II. Suspect Screening
Ion Intensity > 20,000 (+ESI) / 2,000 (-ESI)
Area > 5,000 (+ESI) / 500 (-ESI)
Database of 10,000 compounds 
3590 hits (+ESI) / 1493 hits (-ESI)
Retention time 
prediction model &
(+)ESI or (-)ESI amenable
MS/MS data in 
on-line spectral libraries
4438 hits (+ESI) / 3245 hits (-ESI)
Isotopic fit: ≤ 100 mSigma
2612 hits (+ESI) / 943 hits (-ESI) 3325 hits (+ESI) / 2727 hits (-ESI)
Accuracy: Error ≤ 5 ppm
2061 hits (+ESI) / 703 hits (-ESI) 2997 hits (+ESI) / 2249 hits (-ESI)
Area/Intensity : 7-25 *
610 hits (+ESI) / 150 hits (-ESI) 663 hits (+ESI) / 564 hits (-ESI)
…in progress
* Validation
mean ±2 SD
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II. Suspect Screening
focus on.. 
METABOLITES & TPs
Database of 1,500 human metabolites
of consumed pharmaceuticals 
o 2 generations
• Phase I
• Phase II
• Cytochrome P450
274 hits (+ESI) 
254 hits (-ESI)
Acetylsalicylic acid Met12 
EIC tR= 4.43 min
Accuracy: 1.3 ppm
Isotopic fit: 0.6 mSigma
Predicted tR= 4.39 min
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MS/MS spectra
Hydroxyphenyl acetate
(-ESI)
Retention time prediction
Reject ~30% suspect 
compounds
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Theophylline Met8 
tR= 3.0 min
Accuracy: 0.3 ppm
Isotopic fit: 10 mSigma
Predicted tR= 3.9 min
tR= 3.6 min
Accuracy: 3.2 ppm
Isotopic fit: 10.7 mSigma
Predicted tR= 3.5 min
MS/MS spectra
MS spectra
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Suspect Screening – Human Metabolites
+ ESI- ESI
What proportion of substances present 
in the samples are actually detected 
with target and suspect screening?
TARGET SCREENING
SUSPECT SCREENING
ü Known substance
ü Reference standard 
available
ü Unequivocal identification
ü Possible quantification
ü Suspect substance  
ü No reference standard 
available
ü Qualitative 
detection possible
WHY NON-TARGET? III. Non-target Screening
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ü Usually, many of the most intense peaks do not correspond to
substances included in the target and suspect screening lists.
ü These substances are potentially relevant, due to their high
concentration.
ü Identification of these substances is environmentally relevant 
ü Nevertheless, full identification of unknown compounds is often difficult &
there is no guarantee of a successful outcome 
NON-TARGET SCREENING
ü No former information on the analytes
ü Molecular structures can be assigned on the basis of the exact
mass, isotopic pattern and fragmentation information
III. Non-target Screening
Determination of the Elemental compositions of the unknowns
Automatic peak detection using Algorithms
(High number of peaks)
Full scan (MS) and Product ion spectra (MS/MS)
Accurate mass measurements
•Interpretation of the fragmentation pathway
•Chromatographic retention time plausibility 
Determination and evaluation of candidates
(Tentative) Identification of TPs
STANDARD SCREENING WORKFLOW
Confirmation: RT and MS/MS of chemical 
standards, when available
ü Large effort on manual data evaluation
ü Systematic strategies with automated approaches are required to 
prioritize relevant peaks on which the identification efforts should focus
III. Non-target Screening
11/9/2014
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PROPOSED APPROACH
ü Analyses are carried out in the same way previously described
for target and suspect screening, except that AutoMSMS is
performed (MS/MS data of the 5 most intense peaks per scan
event).
Non-target steps:
ü Blank subtraction
ü Peak peaking procedure
ü Prioritization of peaks for further evaluation
ü Determination of elemental composition
ü Evaluation of possible candidates → Tentative identification
III. Non-target Screening
üUse of metabolomics tools 
BLANK SUBTRACTION 
Sample chromatogram
Procedural blank chromatogram
Blank-subtracted chromatogram
III. Non-target Screening
11/9/2014
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ü Peak peaking: Molecular features Algorithm
• Using Data analysis and Target analysis (Bruker)
• Threshold: Signal/Noise >10
A high number of peaks (> 3500) was obtained
PEAK PEAKING PROCEDURE
III. Non-target Screening
Non-target identification was performed on selected 
masses from the top most intense peaks
PRIORITIZATION OF PEAKS FOR FURTHER EVALUATION
ü Selection of the most relevant from the large peak list
(Not included either in the target or the suspect screening)
Criteria:
• Intensity
• Presence of a distinctive isotopic pattern
III. Non-target Screening
11/9/2014
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1st step: Generation of possible molecular formula(s)
Criteria:
• Mass accuracy → threshold: 5 ppm
• Agreement of the theoretical and measured isotopic pattern
DETERMINATION OF ELEMENTAL COMPOSITION
III. Non-target Screening
üPlausibility of the generated molecules → Use of the Seven Golden Rules software
“Seven golden rules for heuristic filtering of molecular formulas 
obtained by accurate mass spectrometry”
i. Element number restrictions
ii. Lewis and Senior chemical rules check
iii. Isotopic pattern filter
iv. Hydrogen/carbon ratio check
v. Element ratio of nitrogen, oxygen, phosphorus and sulphur vs carbon check
vi. Element ratio probability check
vii. Check of the presence of trimethylsilylated compounds
ü The correct molecular formula is assigned with a probability of 98%,
if the formula exists in a compound database
30 million compounds database → Great reduction of the possibilities
DETERMINATION OF ELEMENTAL COMPOSITION:  SEVEN GOLDEN RULES (SGR)
Kind and Fiehn. BMC Bioinformatics 8:105 (2007)
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ü Number of candidates to one molecular formula: 1 - >2000 
(Chemspider, Pubmed databases)
üDatabases (e.g. MassBank) →Still very limited number of compounds 
(not very useful for non-target screening)
üDeep study of the MS/MS spectra (AutoMSMS analysis)
ü In-silico fragmentation software
§ Smart formula 3D (Bruker)
§ Metfrag
ü Chromatographic retention time plausibility → Application of models
ü Number of data sources and references in different data bases 
(e.g. Chemspider)
EVALUATION OF POSSIBLE CANDIDATES
Approaches for tentative identification:
ü To confirm the identity of a substance, 
purchase of reference standard is required (if available)
ü Peak peaking: Molecular features Algorithm
• Threshold: Signal/Noise >10
A large amount of peaks (> 3500) obtained
Non-target identification was performed on 16 selected masses from the top 
most intense peaks
PEAK PEAKING PRIORIZATION
Compound detected using the TARGET ANALYSIS approach
Metformin
EXAMPLE 1: TREATING METFORMIN AS UNKNOWN
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EXAMPLE 1: TREATING METFORMIN AS UNKNOWN
• Experimental accurate mass:  130.1088
• Retention time: 1.4 min
MS spectra
Number of possible formulas → 1 
(Threshold of 5 ppm and 50 mSigma)
Seven Golden Rules
1 Plausible Molecular formula
C4H12N5
EXAMPLE 1: ELEMENTAL COMPOSITION DETERMINATION
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üC19H28N4
MS/MS Spectra
ü Hits Chemspider: 12
ü Compounds with score > 0.8 → 4
EXAMPLE 1: TENTATIVE IDENTIFICATION
üC19H28N4
EXAMPLE 1: TENTATIVE IDENTIFICATION
ü Metfrag Score: 1 0.86 0.81 0.81
ü Explained Fragments: 5 3 2 2
ü RT Pred. Model: x x
ü Chemspider data sources: 59 5 4 4
ü Chemspider References: 293 6 4 4
Metformin
11/9/2014
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EXAMPLE 1: TENTATIVE IDENTIFICATION
Metformin
APPLICATION OF RETENTION 
TIME PREDICTION MODEL:
Experimental RT = 1.38 min
Predicted RT = 2.5 min
Metfrag peak explanation
• The developed workflow was applied successfully to identify unambiguously 
this compound as Metformin
EXAMPLE 2: APPLICATION OF THE WORKFLOW TO A REAL UNKNOWN
• Experimental accurate mass:  145.0977
• Retention time: 1.9 min
Number of possible formulas 
(Threshold of 5 ppm, 50 mSigma) and 
Seven Golden Rules
1 Plausible Molecular formula
C6H12N2O2
146.0987
145.0977
11/9/2014
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145.097798.0606
103.0877
86.0607
85.0760
MS/MS Spectra
ü Hits Chemspider: 336
ü Compounds with score > 0.9→ 28
ü Only few with more than 3 fragment matches
EXAMPLE 2: TENTATIVE IDENTIFICATION
üC6H12N2O2
EXAMPLE 2: TENTATIVE IDENTIFICATION
ü Metfrag Score: 1 0.97 0.95 0.95 0.95
ü Explained Fragments: 4 4 4 4 3
ü RT Pred. Model: x
ü Chemspider data sources: 1 4 5 17 2
ü Chemspider References: 1 4 5 18 2
145.097798.0606 103.0877
86.0607
85.0760
ü C6H12N2O2
TENTATIVE CANDIDATES
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EXAMPLE 3: TENTATIVE IDENTIFICATION
• Experimental accurate mass:  195.1233
• Retention time: 4.2 min
Number of possible formulas 
(Threshold of 5 ppm, 50 mSigma) 
and Seven Golden Rules
1 Plausible Molecular formula
C8H18O5
163.0861
151.0953107.0707 195.1233
133.0847
89.0596
45.0338
ü Metfrag Score: 1 1 0.95
ü Explained Fragments: 5 5 5
ü RT Pred. Model:
ü Chemspider data sources: 1 67 2
ü Chemspider References: 1 379 2
ü Hits Chemspider: 13
ü 3 compounds with Metfrag score > 0.95 and the others below 0.5
ü C8H18O5
Tetraethyleneglycol
EXAMPLE 3: TENTATIVE IDENTIFICATION
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SUMMARY OF THE LEVELS OF IDENTIFICATION
Retention
time (min)
Mass of ion [m/z] 
(peak of component) Ion type Intensity
Molecular 
formula Proposed identification name
Level of confirmation of 
identification
1.28 164.1282 [M+H]+ 1508655 C7H17NO3 Unequivocal molecular formula
1.91 145.0977 [M+H]+ 2186079 C6H12N2O2
e.g. 4-(2-Hydroxyethyl)-2-
piperazinone Tentative candidates
2.27 96.0452 [M+H]+ 1145713 C5H5NO 2-Formyl-1H-pyrrole Probable structure
4.19 195.1233 [M+H]+ 1405658 C8H18O5 tetraethyleneglycol Tentative candidate
4.68 135.1018 [M+H]+ 1122821 C6H14O3 Unequivocal molecular formula
4.98 424.1857 [M+H]+ 1263654 Exact mass of interest
5.09 358.2078 [M+NH4]+ 1264684 C15H24N4O5 Unequivocal molecular formula
5.16 283.1753 [M+H]+ 1262520 C13H22N4O3 Unequivocal molecular formula
5.2 468.2108 [M+H]+ 1263126 Exact mass of interest
5.24 374.239 [M+H]+ 1184473 C16H31N5O5 Unequivocal molecular formula
5.73 149.1176 [M+H]+ 1688072 C7H16O3 Unequivocal molecular formula
6.13 520.333 [M+H]+ 1262524 Exact mass of interest
6.44 608.3854 [M+H]+ 1262588 Exact mass of interest
9.1 232.1913 [M+H]+ 1160646 C12H25NO3
e.g. N,N-Bis(2-
hydroxyethyl)octanamide Tentative candidates
9.4 191.1647 [M+H]+ 1410087 C10H22O3 Unequivocal molecular formula
12.69 316.1955 [M+H]+ 1137576 C16H29NO3S
e.g. 1-{(2-Methoxyethyl)[(5-
methyl-2-thienyl)methyl] 
amino}-3-[(2-methyl-2-
propanyl)oxy]-2-propanol
Tentative candidates
ü 16 evaluated top intense peaks in +ESI mode
ü 5 Tentatively candidates
ü 7 Unequivocal molecular formula 
ü 4 Exact mass of interest 
Conclusions
• Target and suspect HRMS screening workflows 
were developed and validated
• Target screening can identify app. 10% of the 
obtained peaks from a LC-QTOFMS analysis
• Suspect screening can explained app. 20% of 
the obtained peaks
• Non-target workflows are needed for the 
tentative identification of the highly abundant 
peaks 
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